The effects of postmenopausal hormone replacement therapy on hemostatic variables

A meta-analysis of 46 studies

N. Ács, Z. Vajó, Z. Miklos, G. Siklosi, F. Paulin, J. V. Felicetta, B. Székåcs

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The aim of the study was to summarize and reanalyze all available data from the literature to study the overall effect of postmenopausal hormone replacement therapy (HRT) and its various forms on hemostatic variables. Studies were identified from literature searches by Medline and Index Medicus, review articles and personal communications. Reference lists of all articles were checked to find additional studies. Principal investigators were contacted and asked to provide additional data if required. Data were collected separately for each factor of the hemostatic system. Studies written in any language were included. Each collection of studies was analyzed using standard methods for meta-analysis. A total of 76 arms of 48 studies were eligible for analysis. This included 6119 women using HRT and 24 974 non-users. The age of investigated women was 40-68 years. HRT was associated with significantly decreased levels of fibrinogen, factor VIII, antithrombin III, and proteins C and S, but significantly increased plasminogen levels. HRT with estrogen alone or in combination with progestins, oral vs. transdermal regimens, different estrogen preparations and various progestins induced significantly different changes in many cases. In conclusion, HRT was associated with changes that could explain the increased rate of venous thrombotic events, and also with some changes that could account for beneficial vascular effects. Surprisingly, the addition of progestins induced favorable changes in many cases. Also, transdermal use was associated with more beneficial effects than oral regimens in some cases.

Original languageEnglish
Pages (from-to)335-346
Number of pages12
JournalGynecological Endocrinology
Volume16
Issue number4
Publication statusPublished - Aug 2002

Fingerprint

Estrogen Replacement Therapy
Hormone Replacement Therapy
Hemostatics
Meta-Analysis
Progestins
Estrogens
Antithrombin Proteins
Antithrombin III
Plasminogen
Protein S
Factor VIII
Protein C
MEDLINE
Fibrinogen
Blood Vessels
Language
Communication
Research Personnel

Keywords

  • Coagulation
  • Fibrinogen
  • HRT
  • Protein C
  • Protein S
  • Thrombosis

ASJC Scopus subject areas

  • Endocrinology
  • Obstetrics and Gynaecology

Cite this

The effects of postmenopausal hormone replacement therapy on hemostatic variables : A meta-analysis of 46 studies. / Ács, N.; Vajó, Z.; Miklos, Z.; Siklosi, G.; Paulin, F.; Felicetta, J. V.; Székåcs, B.

In: Gynecological Endocrinology, Vol. 16, No. 4, 08.2002, p. 335-346.

Research output: Contribution to journalArticle

Ács, N, Vajó, Z, Miklos, Z, Siklosi, G, Paulin, F, Felicetta, JV & Székåcs, B 2002, 'The effects of postmenopausal hormone replacement therapy on hemostatic variables: A meta-analysis of 46 studies', Gynecological Endocrinology, vol. 16, no. 4, pp. 335-346.
Ács, N. ; Vajó, Z. ; Miklos, Z. ; Siklosi, G. ; Paulin, F. ; Felicetta, J. V. ; Székåcs, B. / The effects of postmenopausal hormone replacement therapy on hemostatic variables : A meta-analysis of 46 studies. In: Gynecological Endocrinology. 2002 ; Vol. 16, No. 4. pp. 335-346.
@article{d1a03e464cd544b69e12ded725249a72,
title = "The effects of postmenopausal hormone replacement therapy on hemostatic variables: A meta-analysis of 46 studies",
abstract = "The aim of the study was to summarize and reanalyze all available data from the literature to study the overall effect of postmenopausal hormone replacement therapy (HRT) and its various forms on hemostatic variables. Studies were identified from literature searches by Medline and Index Medicus, review articles and personal communications. Reference lists of all articles were checked to find additional studies. Principal investigators were contacted and asked to provide additional data if required. Data were collected separately for each factor of the hemostatic system. Studies written in any language were included. Each collection of studies was analyzed using standard methods for meta-analysis. A total of 76 arms of 48 studies were eligible for analysis. This included 6119 women using HRT and 24 974 non-users. The age of investigated women was 40-68 years. HRT was associated with significantly decreased levels of fibrinogen, factor VIII, antithrombin III, and proteins C and S, but significantly increased plasminogen levels. HRT with estrogen alone or in combination with progestins, oral vs. transdermal regimens, different estrogen preparations and various progestins induced significantly different changes in many cases. In conclusion, HRT was associated with changes that could explain the increased rate of venous thrombotic events, and also with some changes that could account for beneficial vascular effects. Surprisingly, the addition of progestins induced favorable changes in many cases. Also, transdermal use was associated with more beneficial effects than oral regimens in some cases.",
keywords = "Coagulation, Fibrinogen, HRT, Protein C, Protein S, Thrombosis",
author = "N. {\'A}cs and Z. Vaj{\'o} and Z. Miklos and G. Siklosi and F. Paulin and Felicetta, {J. V.} and B. Sz{\'e}k{\aa}cs",
year = "2002",
month = "8",
language = "English",
volume = "16",
pages = "335--346",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - The effects of postmenopausal hormone replacement therapy on hemostatic variables

T2 - A meta-analysis of 46 studies

AU - Ács, N.

AU - Vajó, Z.

AU - Miklos, Z.

AU - Siklosi, G.

AU - Paulin, F.

AU - Felicetta, J. V.

AU - Székåcs, B.

PY - 2002/8

Y1 - 2002/8

N2 - The aim of the study was to summarize and reanalyze all available data from the literature to study the overall effect of postmenopausal hormone replacement therapy (HRT) and its various forms on hemostatic variables. Studies were identified from literature searches by Medline and Index Medicus, review articles and personal communications. Reference lists of all articles were checked to find additional studies. Principal investigators were contacted and asked to provide additional data if required. Data were collected separately for each factor of the hemostatic system. Studies written in any language were included. Each collection of studies was analyzed using standard methods for meta-analysis. A total of 76 arms of 48 studies were eligible for analysis. This included 6119 women using HRT and 24 974 non-users. The age of investigated women was 40-68 years. HRT was associated with significantly decreased levels of fibrinogen, factor VIII, antithrombin III, and proteins C and S, but significantly increased plasminogen levels. HRT with estrogen alone or in combination with progestins, oral vs. transdermal regimens, different estrogen preparations and various progestins induced significantly different changes in many cases. In conclusion, HRT was associated with changes that could explain the increased rate of venous thrombotic events, and also with some changes that could account for beneficial vascular effects. Surprisingly, the addition of progestins induced favorable changes in many cases. Also, transdermal use was associated with more beneficial effects than oral regimens in some cases.

AB - The aim of the study was to summarize and reanalyze all available data from the literature to study the overall effect of postmenopausal hormone replacement therapy (HRT) and its various forms on hemostatic variables. Studies were identified from literature searches by Medline and Index Medicus, review articles and personal communications. Reference lists of all articles were checked to find additional studies. Principal investigators were contacted and asked to provide additional data if required. Data were collected separately for each factor of the hemostatic system. Studies written in any language were included. Each collection of studies was analyzed using standard methods for meta-analysis. A total of 76 arms of 48 studies were eligible for analysis. This included 6119 women using HRT and 24 974 non-users. The age of investigated women was 40-68 years. HRT was associated with significantly decreased levels of fibrinogen, factor VIII, antithrombin III, and proteins C and S, but significantly increased plasminogen levels. HRT with estrogen alone or in combination with progestins, oral vs. transdermal regimens, different estrogen preparations and various progestins induced significantly different changes in many cases. In conclusion, HRT was associated with changes that could explain the increased rate of venous thrombotic events, and also with some changes that could account for beneficial vascular effects. Surprisingly, the addition of progestins induced favorable changes in many cases. Also, transdermal use was associated with more beneficial effects than oral regimens in some cases.

KW - Coagulation

KW - Fibrinogen

KW - HRT

KW - Protein C

KW - Protein S

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0036694014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036694014&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 335

EP - 346

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 4

ER -